Leukemia
Seiten
2010
Crc Press Inc (Verlag)
978-1-4200-4353-2 (ISBN)
Crc Press Inc (Verlag)
978-1-4200-4353-2 (ISBN)
- Titel wird leider nicht erscheinen
- Artikel merken
Translational research is fundamental to the development of targeted therapies and treatments for leukemia. This book offers a discussion of translational research in leukemia and aims to equip clinicians and researchers with the necessary context and perspective to knowledgeably and effectively deploy therapies into day-to-day clinical practice.
Translational research is fundamental to the development of targeted therapies and new treatments for leukemia. This source provides a thorough discussion of translational research in leukemia and will equip clinicians and researchers with the necessary context and perspective to knowledgeably and effectively deploy new therapies into day-to-day clinical practice. With full-color photographs, this source covers the entire scope of translational work in leukemia, from advances in biology and classification, to DNA-methylation, apoptosis, differentiation, and immune therapy, plus analyses of specific therapeutic targets such as BCR-ABL and Jak2.
Translational research is fundamental to the development of targeted therapies and new treatments for leukemia. This source provides a thorough discussion of translational research in leukemia and will equip clinicians and researchers with the necessary context and perspective to knowledgeably and effectively deploy new therapies into day-to-day clinical practice. With full-color photographs, this source covers the entire scope of translational work in leukemia, from advances in biology and classification, to DNA-methylation, apoptosis, differentiation, and immune therapy, plus analyses of specific therapeutic targets such as BCR-ABL and Jak2.
Advances in Biology and Classification. Mouse Models. Stem Cells. Pharmacogenomics.Microarrays/gene expression. Minimal residual disease. Translational Therapeutic Approaches.DNA-methylation. Ras/prenylation. Transcription Factors. Apoptosis. Differentiation (ATRA/As). Immune Therapy. Therapeutic Targets. BCR-ABL. FLT3. HDAC and Chromatin. Jak2
Erscheint lt. Verlag | 15.12.2010 |
---|---|
Zusatzinfo | 40 black & white illustrations, 16 colour illustrations |
Verlagsort | Bosa Roca |
Sprache | englisch |
Maße | 152 x 229 mm |
Themenwelt | Medizin / Pharmazie ► Allgemeines / Lexika |
Medizinische Fachgebiete ► Innere Medizin ► Hämatologie | |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
ISBN-10 | 1-4200-4353-6 / 1420043536 |
ISBN-13 | 978-1-4200-4353-2 / 9781420043532 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Hämatologie und Internistische Onkologie
Buch | Softcover (2023)
ecomed-Storck GmbH (Verlag)
CHF 179,95
Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 73,00
Buch | Softcover (2023)
Deutscher Ärzteverlag
CHF 41,95